If you have wondered whether kratom is an opioid, you are asking a sharper question than most of the labels on the shelf will answer.
The honest version sits between two wrong answers. Kratom is not a classic opioid in the way heroin or oxycodone is — but it acts on the same receptors, and it can create the same kind of dependence. That gap between “it’s basically heroin” and “it’s just a plant” is where most of the confusion lives.
This page gives the straight answer, then covers what actually changed in 2026 — the rise of concentrated 7-OH products — along with what kratom withdrawal looks like and whether Suboxone helps.
Is Kratom an Opioid? The Short Answer
Kratom is not chemically a classic opioid, but its active compounds act on the brain’s opioid receptors — which is why it produces opioid-like effects and opioid-like dependence.
Kratom comes from the leaves of Mitragyna speciosa, a tree native to Southeast Asia. Its two main active compounds, mitragynine and 7-hydroxymitragynine (7-OH), bind to the same mu-opioid receptors that prescription opioids target.
Federal agencies treat it as opioid-acting: the Drug Enforcement Administration lists kratom as a drug of concern, and the National Institute on Drug Abuse notes that its compounds activate the same brain receptors as other drugs with known addictive potential.
So the precise answer is: not an opioid by origin, but opioid-acting by mechanism. That distinction matters — because it is exactly why people underestimate it.
How Kratom Works in the Brain
Kratom’s effects depend on dose: lower amounts tend to act like a stimulant, while higher amounts produce opioid-like sedation and pain relief.
This dual effect is well documented in the clinical literature. At low doses, people who use kratom report increased energy and alertness; at higher doses, they report sedation and pain relief closer to an opioid.
Mitragynine, 7-OH, and the mu-opioid receptor
Mitragynine and 7-OH are partial agonists at the mu-opioid receptor, meaning they activate it but not as fully as a drug like morphine.
They are also described in research as G-protein-biased agonists that do not strongly recruit a signaling protein called beta-arrestin-2.
That detail has a practical consequence. Beta-arrestin-2 signaling is linked to the respiratory depression that makes classic opioid overdose so lethal, so leaf kratom tends to suppress breathing less than morphine or fentanyl. Lower risk is not the same as no risk — and concentrated products change that math, as the next section explains.
Why low doses stimulate and high doses sedate
The dose-dependent effect is why kratom gets marketed for two opposite reasons — energy and focus on one hand, pain and anxiety relief on the other.
It is also why dependence can build quietly. Someone using kratom for daytime energy and again for evening pain may be dosing far more often than they realize.
Where 7-OH regulation stands in 2026
On July 29, 2025, the FDA recommended that the DEA classify concentrated 7-OH products as Schedule I controlled substances — the most aggressive federal action on kratom compounds since 2016.
FDA leadership has publicly described concentrated 7-OH as a potent opioid and a major public-health concern.
As of mid-2026, the DEA had not finalized that scheduling, so concentrated 7-OH remains federally unscheduled even as several states — including Florida — have restricted it under their own laws. The recommendation targeted concentrated products specifically, not natural whole-leaf kratom.
The takeaway for anyone using these products: the legal status is unsettled, but the pharmacology is not. Concentrated 7-OH behaves like a potent opioid.
Is Kratom Addictive?
Yes — regular kratom use can lead to tolerance, physical dependence, and a pattern of use that meets the clinical definition of a substance use disorder.
The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) has no kratom-specific diagnosis, so clinicians generally assess kratom use against opioid use disorder criteria. Dependence tends to build faster and harder with concentrated 7-OH than with leaf.
Tolerance, dependence, and signs to recognize
Dependence usually shows up gradually: needing more to get the same effect, dosing on a schedule to avoid feeling unwell, and finding it hard to stop despite wanting to.
Common signs include:
- Needing larger or more frequent doses over time to feel normal
- Feeling withdrawal symptoms — restlessness, irritability, aches — when a dose is missed
- Spending more money or planning around having kratom on hand
- Continuing use even after it starts affecting sleep, mood, work, or relationships
Many people who use kratom are trying to manage something else — chronic pain, anxiety, depression, or withdrawal from prescription opioids. That underlying reason matters, and it shapes what effective treatment looks like.
Other health risks
Beyond dependence, Mayo Clinic notes that kratom has been linked to liver injury, seizures, and high blood pressure, and that unregulated products have been found contaminated with heavy metals and salmonella.
Kratom use during pregnancy has also been associated with newborn withdrawal. Because kratom is unregulated, potency and purity vary widely from product to product.
A quick gut check. If reading the signs above felt a little too familiar, that recognition is worth acting on — not panicking over. A conversation is free, and your insurance may cover more than you expect. Call Discover Recovery at 866.719.2173.
Kratom Withdrawal: Symptoms and Timeline
Kratom withdrawal resembles opioid withdrawal because of how it acts on mu-opioid receptors — generally milder than withdrawal from strong opioids like fentanyl, though concentrated 7-OH narrows that gap.
Withdrawal happens because the brain adapts to kratom’s presence. When it is suddenly removed, the body needs time to rebalance, and that adjustment produces symptoms.
Common withdrawal symptoms
Symptoms are a mix of physical and psychological, and they tend to come in waves:
- Muscle aches, joint pain, and flu-like discomfort
- Nausea, stomach cramps, and diarrhea
- Sweating, chills, and a runny nose
- Insomnia and restlessness
- Anxiety, irritability, low mood, and cravings
The withdrawal timeline
Most people who stop after regular use follow a recognizable pattern, though duration varies with how much, how long, and what form was used.
| Stage | Timing | What typically happens |
| Onset | 6–12 hours after last dose | Early restlessness, anxiety, mild aches |
| Peak | Days 2–4 | Most intense physical symptoms and cravings |
| Acute fade | By about day 7 | Physical symptoms ease substantially |
| Lingering | Weeks to months | Low mood, poor sleep, and cravings can persist (post-acute withdrawal) |
General clinical pattern reported in peer-reviewed case literature; individual timelines vary.
How kratom withdrawal compares to classic opioid withdrawal
Kratom withdrawal follows the same general arc as opioid withdrawal, but for leaf kratom it is usually shorter and less medically dangerous — though still intense enough to drive relapse.
| Dimension | Kratom (leaf) | Classic opioids (heroin, oxycodone, fentanyl) |
| Onset after last dose | ~6–12 hours | ~8–24 hours (sooner for short-acting, later for long-acting) |
| Peak intensity | Days 2–4 | Days 1–3, typically more severe |
| Acute physical phase | ~5–7 days | ~7–14 days (longer for methadone) |
| Overall severity | Often milder, flu-like | Generally more intense |
| Main medical risk | Dehydration; relapse | Dehydration; high relapse-to-overdose risk |
| Responds to buprenorphine | Yes, in case reports | Yes, well established |
Sources: Mayo Clinic, NIDA, and peer-reviewed case literature. Timelines are typical patterns, not guarantees.
Concentrated 7-OH is the exception to the “milder” rule. Because it behaves more like a potent opioid, its withdrawal can be more severe and is safest managed with medical support — especially when other substances are involved.
Does Suboxone Help With Kratom Withdrawal?
Suboxone can help some people through kratom withdrawal, but the evidence is built on clinical case reports rather than large trials — so it belongs in the hands of a prescriber, not a do-it-yourself plan.
Suboxone contains buprenorphine, a partial opioid agonist — a medication that activates opioid receptors enough to ease withdrawal and cravings without producing a strong high. Because kratom acts on those same receptors, buprenorphine can stabilize the same system.
A University of Illinois Chicago drug information review found that buprenorphine and buprenorphine-naloxone have the most published support for kratom withdrawal, with the strongest results in people who also had a history of opioid use.
Two honest caveats matter here. There are no large randomized trials specific to kratom, so this is an off-label, case-by-case clinical decision. And timing is critical — starting buprenorphine too early can trigger precipitated withdrawal, a sudden and severe spike in symptoms, which is why it must be clinician-guided. Other medications, including clonidine, also appear in the case literature.
Getting Help for Kratom Dependence in Washington & Oregon
Kratom dependence is treatable, and the approach mirrors evidence-based opioid care — medically supervised detox when needed, medication support, and treatment for whatever the kratom was managing underneath.
Discover Recovery offers medically supervised medical detox and medication-assisted treatment at CARF-accredited locations in Long Beach and Camas, Washington, and Portland, Oregon.
Because so many people use kratom to self-manage pain, anxiety, depression, or trauma, treating the underlying condition alongside the dependence — not after it — is often what makes recovery hold. That co-occurring care is core to how Discover Recovery works.
You don’t have to figure this out alone. A conversation is free, and verifying your coverage takes only a few minutes. Call Discover Recovery at 866.719.2173 or verify your insurance online.
If you or someone you are with is in immediate danger, call 911. For free, confidential support any time, the SAMHSA National Helpline is 1-800-662-4357.
Frequently Asked Questions
Is kratom legal in the U.S.?
Kratom is not federally scheduled, so it remains legal at the federal level in most states. However, a number of states and cities have banned or restricted it, and some have specifically restricted concentrated 7-OH products — so legality depends on where you live.
Can you overdose on kratom?
Yes, though leaf kratom carries a lower risk of fatal respiratory depression than strong opioids. Risk rises sharply with concentrated 7-OH products and when kratom is combined with other substances like alcohol, benzodiazepines, or opioids, and deaths have been reported.
Is it safe to use kratom to get off opioids?
Many people try this, and some report it helps in the short term, but it carries a real risk of simply trading one dependence for another. Proven medications for opioid use disorder, prescribed and monitored by a clinician, are a safer path than self-managing with kratom.
Should you quit kratom cold turkey?
For light, short-term use, some people stop without major problems, but quitting abruptly after heavy or concentrated-7-OH use can be rough and increases relapse risk. A clinician can guide a safer taper or detox — this isn’t something to plan from an online forum.
Is kratom withdrawal medically dangerous?
For most leaf-kratom users, withdrawal is uncomfortable rather than life-threatening, though dehydration from vomiting and diarrhea is a real concern. Withdrawal from concentrated 7-OH, or alongside other substances, is more serious and is safest with medical supervision.
How long does kratom stay in your system?
Kratom’s compounds are generally detectable for a few days, though this varies with dose, frequency, and individual metabolism. Standard drug-screening panels often do not test for kratom, so tell any treating clinician if you have been using it.
Reviewed By: Dr. Kevin Fischer, M.D.
Kevin Fischer, MD is an experienced leader in the fields of Internal Medicine and Addiction Medicine. He works with patients suffering from Substance Use Disorder to evaluate their comprehensive health needs and prescribe Medication-Assisted Treatment (MAT). In addition, he mentors aspiring health professionals and leads collaborative care through team-based medical models. He also directs treatment strategies and streamlines clinical protocols for effective substance use recovery.